ArticleCureus2024
Very Low-Dose Sublingual Ketamine for Borderline Personality Disorder and Treatment-Resistant Depression.
Mitchell Liester et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleCureus2024
Mitchell Liester et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.